Exploring the reasons behind the Belgian prohibition of the commercialization of the plant Artemisia annua.

Authors

  • Marie mathilde Vandenschrick KU Leuven

DOI:

https://doi.org/10.22370/pe.2022.13.3444

Keywords:

epistemic coloniality, technocracy, commodification of nature, traditional Chinese medicine, Artemisia annua

Abstract

This paper explores the prohibition of the commercialization of the plant Artemisia annua for fighting malaria through three political ecology concepts. Firstly, from the perspective of epistemic coloniality, the power/knowledge dimension is highlighted as key to understand how the scientific knowledge produced in the West renders invisible whatever is outside that canon (among which the Artemisia annua tea infusion). Secondly, using a technocratic lens, I identify a techno-elite composed by companies and individuals which intensively promote the standard drugs (ACTs) at the expense of the traditional tea infusion, and that for profitability reasons. Finally, through the logic of commodification of nature, I argue that the Artemisia annua tea infusion struggles to reach scientific validity because it is not (yet) profitable enough to acquire that status.

Downloads

Download data is not yet available.

Author Biography

Marie mathilde Vandenschrick, KU Leuven

BA. OF LAW, UNIVERSITÉ DE SAINT LOUIS - BRUXELLES. MSC. OF SUSTAINABLE DEVELOPMENT, KU LEUVEN

References

ABBOTT, R. (2014). Documenting traditional medical knowledge. World Intellectual Property Organization. https://www.wipo.int/export/sites/www/tk/en/resources/pdf/medical_tk.pdf

ARRÊTÉ ROYAL DU 29 août 1997 relatif à la fabrication et au commerce de denrées alimentaires composées ou contenant des plantes ou préparations de plantes (B.S.). https://www.health.belgium.be/fr/arrete-royal-du-29-aout-1997-plantes https://www.ejustice.just.fgov.be/doc/rech_f.htm

CASTREE, N. (2005). Nature. New York, NY: Routledge.

CHU. (2018, April). ATC Pharma, 15 ans avant de rejoindre l’officine. n°23. Le Patient. https://www.chuliege.be/jcms/c2_17368061/fr/espace-de-documentation-publications?start=0&pageSize=10&pagerAll=true&reverse=false

CRUTZEN, B. (director) & Caméra One Télévision, Zistoires & RTBF (producers) (2017). Malaria business: les laboratoires contre la médecine naturelle. [Motion picture]. France/Belgique : France Télévisions. https://www.youtube.com/watch?v=W6TgP5RlsDQ

CZECHOWSKI, T., WEATHERS, P. J., BRODELIUS, P. E., BROWN, G. D., & GRAHAM, I. A. (2020). Artemisinin - from traditional Chinese medicine to artemisinin combination therapies: four decades of research on the biochemistry, physiology, and breeding of Artemisia annua. Frontiers in Plant Science, 11, 594565. https://doi.org/10.3389/fpls.2020.594565

DADDY, N. B., KALISYA, L. M., BAGIRE, P. G., WATT, R. L., TOWLER, M. J., & WEATHERS, P. J. (2017). Artemisia annua dried leaf tablets treated malaria resistant to ACT and i.v. artesunate: Case reports. Phytomedicine : international journal of phytotherapy and phytopharmacology, 32, 37–40. https://doi.org/10.1016/j.phymed.2017.04.006

DE SOUSA SANTOS, B. (2012). Public sphere and epistemologies of the South. Africa Development, 37(1), 43-67.

GINSBURG, H., & DEHARO, E. (2011). A call for using natural compounds in the development of new antimalarial treatments–an introduction. Malaria journal, 10(1), 1-7. https://doi.org/10.1186/1475-2875-10-S1-S1

GRUESSNER, B. M., CORNET-VERNET, L., DESROSIERS, M. R., LUTGEN, P., TOWLER, M. J., & WEATHERS, P. J. (2019). It is not just artemisinin: Artemisia sp. for treating diseases including malaria and schistosomiasis. Phytochemistry Reviews, 18(6), 1509-1527. https://doi.org/10.1007/s11101-019-09645-9

GUMBO, M.T. (2017). An Indigenous Perspective on Technology Education. IGI Global. https://doi.org/10.4018/978-1-5225- 0838-0.ch008

IDELAND, M. (2018). Science, coloniality, and “the great rationality divide”. Science & Education, 27(7), 783-803. http://doi.org/10.1007/s11191-018-0006-8

INGABIRE, C. (2021). Quelles sont les difficultés rencontrées par un traitement naturel lors de son insertion dans les systèmes de santé africains ? Le cas de la malaria et la tisane d’Artemisia. (Master thesis. Louvain School of Management, Université Catholique de Louvain) Retrieved from http://hdl.handle.net/2078.1/thesis:26040

HAUSSE, G. (2019). Are non-pharmaceutical forms of Artemisia annua a solution for the control and eradication of uncomplicated plasmodium falciparum malaria? - An overview of the current situation. (Master thesis, Université de Namur).

JASANOFF, S. (2016). The ethics of invention: technology and the human future. New York, NY: WW Norton & Company.

LUTGEN, P. (2015, July 20). Artemisia against malaria: efficient but banished. Malaria World. Retrieved from https://www.malariaworld.org/blogs/artemisia-against-malaria-efficientbanished

PELUSO, N. L. (2012). What’s nature got to do with it? A situated historical perspective on socio‐natural commodities. Development and Change, 43(1), 79-104. https://doi.org/10.1111/j.1467-7660.2012.01755.x

PHILLIPS & ROZWORSKI. (2019). People’s Republic of Walmart. How the largest world’s biggest corporations are laying the foundation for socialism. New York, NY: Verso.

WATTS, M. (2013). Commodities. In P. Cloke, P. Crang, & M. Goodwin (Eds.). Introducing human geographies (pp.391-312). New York, NY: Routledge (3rd ed.). https://doi.org/10.4324/9780203529225

WEATHERS, P. J., TOWLER, M., HASSANALI, A., LUTGEN, P., & ENGEU, P. O. (2014). Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries? World journal of pharmacology, 3(4), 39. https://doi.org/10.5497/wjp.v3.i4.39

WORLD HEALTH ORGANIZATION (2012). Effectiveness of non-pharmaceutical forms of artemisia annua L. against malaria: WHO position statement. World Health Organization. https://apps.who.int/iris/handle/10665/337992

Downloads

Published

2023-01-11

How to Cite

Vandenschrick, M. mathilde. (2023). Exploring the reasons behind the Belgian prohibition of the commercialization of the plant Artemisia annua. Economic Profiles, (13). https://doi.org/10.22370/pe.2022.13.3444

Issue

Perfiles Económicos n. 13 dic. 2022

Section

Sección Artículos

License

Those authors who have publications with this journal accept the following terms:

1.- Authors will retain their copyright and grant the journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License (CC BY-NC-ND 4.0 International) https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es which allows third parties to share, copy and redistribute the material in any medium or format.

  • Attribution: credit must be given appropriately, provide a link to the license, and indicate if changes have been made. It may be done in any reasonable manner, but not in such a way as to suggest that the use is supported by the licensor.
  • Non-Commercial: No use of the material may be made for commercial purposes.
  • No Derivatives: Any remix, transformation or creation from the material, the modified material may not be distributed.
  • No Additional Restrictions: No legal terms or technological measures may be applied that legally restrict others from making any use permitted by the license.


2.- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.


3.- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The Open Access Effect).